1 Market Overview

1.1 Product Overview and Scope of Anti-tumor Drug

1.2 Classification of Anti-tumor Drug by Type

1.2.1 Overview: Global Anti-tumor Drug Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Anti-tumor Drug Revenue Market Share by Type in 2021

1.2.3 Cytotoxic Drugs

1.2.4 Non-cytotoxic Drugs

1.3 Global Anti-tumor Drug Market by Application

1.3.1 Overview: Global Anti-tumor Drug Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Alkylating Agents

1.3.3 Anti-Metabolism Drugs

1.3.4 Platinum Antineoplastic Agents

1.3.5 Anthracycline Antitumor Drugs

1.3.6 Microtubule Stabilizer

1.3.7 Endocrine Therapy Drugs

1.3.8 Immunotherapy Drugs

1.3.9 Gene Therapy Drugs

1.3.10 Targeted Antineoplastic Drugs

1.4 Global Anti-tumor Drug Market Size & Forecast

1.5 Global Anti-tumor Drug Market Size and Forecast by Region

1.5.1 Global Anti-tumor Drug Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Anti-tumor Drug Market Size by Region, (2017-2022)

1.5.3 North America Anti-tumor Drug Market Size and Prospect (2017-2028)

1.5.4 Europe Anti-tumor Drug Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Anti-tumor Drug Market Size and Prospect (2017-2028)

1.5.6 South America Anti-tumor Drug Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Anti-tumor Drug Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Anti-tumor Drug Market Drivers

1.6.2 Anti-tumor Drug Market Restraints

1.6.3 Anti-tumor Drug Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Anti-tumor Drug Product and Solutions

2.1.4 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Roche Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Anti-tumor Drug Product and Solutions

2.2.4 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Celgene

2.3.1 Celgene Details

2.3.2 Celgene Major Business

2.3.3 Celgene Anti-tumor Drug Product and Solutions

2.3.4 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Celgene Recent Developments and Future Plans

2.4 Bristol-Myers Squibb

2.4.1 Bristol-Myers Squibb Details

2.4.2 Bristol-Myers Squibb Major Business

2.4.3 Bristol-Myers Squibb Anti-tumor Drug Product and Solutions

2.4.4 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.5 Amgen

2.5.1 Amgen Details

2.5.2 Amgen Major Business

2.5.3 Amgen Anti-tumor Drug Product and Solutions

2.5.4 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Amgen Recent Developments and Future Plans

2.6 Johnson & Johnson

2.6.1 Johnson & Johnson Details

2.6.2 Johnson & Johnson Major Business

2.6.3 Johnson & Johnson Anti-tumor Drug Product and Solutions

2.6.4 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Johnson & Johnson Recent Developments and Future Plans

2.7 Pfizer

2.7.1 Pfizer Details

2.7.2 Pfizer Major Business

2.7.3 Pfizer Anti-tumor Drug Product and Solutions

2.7.4 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Pfizer Recent Developments and Future Plans

2.8 Takeda

2.8.1 Takeda Details

2.8.2 Takeda Major Business

2.8.3 Takeda Anti-tumor Drug Product and Solutions

2.8.4 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Takeda Recent Developments and Future Plans

2.9 Eli Lilly

2.9.1 Eli Lilly Details

2.9.2 Eli Lilly Major Business

2.9.3 Eli Lilly Anti-tumor Drug Product and Solutions

2.9.4 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Eli Lilly Recent Developments and Future Plans

2.10 AstraZeneca

2.10.1 AstraZeneca Details

2.10.2 AstraZeneca Major Business

2.10.3 AstraZeneca Anti-tumor Drug Product and Solutions

2.10.4 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 AstraZeneca Recent Developments and Future Plans

2.11 Astellas

2.11.1 Astellas Details

2.11.2 Astellas Major Business

2.11.3 Astellas Anti-tumor Drug Product and Solutions

2.11.4 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Astellas Recent Developments and Future Plans

2.12 Merck & Co

2.12.1 Merck & Co Details

2.12.2 Merck & Co Major Business

2.12.3 Merck & Co Anti-tumor Drug Product and Solutions

2.12.4 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Merck & Co Recent Developments and Future Plans

2.13 Sanofi

2.13.1 Sanofi Details

2.13.2 Sanofi Major Business

2.13.3 Sanofi Anti-tumor Drug Product and Solutions

2.13.4 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Sanofi Recent Developments and Future Plans

2.14 Bayer

2.14.1 Bayer Details

2.14.2 Bayer Major Business

2.14.3 Bayer Anti-tumor Drug Product and Solutions

2.14.4 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Bayer Recent Developments and Future Plans

2.15 Biogen Idec

2.15.1 Biogen Idec Details

2.15.2 Biogen Idec Major Business

2.15.3 Biogen Idec Anti-tumor Drug Product and Solutions

2.15.4 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Biogen Idec Recent Developments and Future Plans

2.16 Eisai

2.16.1 Eisai Details

2.16.2 Eisai Major Business

2.16.3 Eisai Anti-tumor Drug Product and Solutions

2.16.4 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Eisai Recent Developments and Future Plans

2.17 Teva

2.17.1 Teva Details

2.17.2 Teva Major Business

2.17.3 Teva Anti-tumor Drug Product and Solutions

2.17.4 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Teva Recent Developments and Future Plans

2.18 Otsuka

2.18.1 Otsuka Details

2.18.2 Otsuka Major Business

2.18.3 Otsuka Anti-tumor Drug Product and Solutions

2.18.4 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Otsuka Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Anti-tumor Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Anti-tumor Drug Players Market Share in 2021

3.2.2 Top 10 Anti-tumor Drug Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Anti-tumor Drug Players Head Office, Products and Services Provided

3.4 Anti-tumor Drug Mergers & Acquisitions

3.5 Anti-tumor Drug New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Anti-tumor Drug Revenue and Market Share by Type (2017-2022)

4.2 Global Anti-tumor Drug Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Anti-tumor Drug Revenue Market Share by Application (2017-2022)

5.2 Global Anti-tumor Drug Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Anti-tumor Drug Revenue by Type (2017-2028)

6.2 North America Anti-tumor Drug Revenue by Application (2017-2028)

6.3 North America Anti-tumor Drug Market Size by Country

6.3.1 North America Anti-tumor Drug Revenue by Country (2017-2028)

6.3.2 United States Anti-tumor Drug Market Size and Forecast (2017-2028)

6.3.3 Canada Anti-tumor Drug Market Size and Forecast (2017-2028)

6.3.4 Mexico Anti-tumor Drug Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Anti-tumor Drug Revenue by Type (2017-2028)

7.2 Europe Anti-tumor Drug Revenue by Application (2017-2028)

7.3 Europe Anti-tumor Drug Market Size by Country

7.3.1 Europe Anti-tumor Drug Revenue by Country (2017-2028)

7.3.2 Germany Anti-tumor Drug Market Size and Forecast (2017-2028)

7.3.3 France Anti-tumor Drug Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Anti-tumor Drug Market Size and Forecast (2017-2028)

7.3.5 Russia Anti-tumor Drug Market Size and Forecast (2017-2028)

7.3.6 Italy Anti-tumor Drug Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Anti-tumor Drug Revenue by Type (2017-2028)

8.2 Asia-Pacific Anti-tumor Drug Revenue by Application (2017-2028)

8.3 Asia-Pacific Anti-tumor Drug Market Size by Region

8.3.1 Asia-Pacific Anti-tumor Drug Revenue by Region (2017-2028)

8.3.2 China Anti-tumor Drug Market Size and Forecast (2017-2028)

8.3.3 Japan Anti-tumor Drug Market Size and Forecast (2017-2028)

8.3.4 South Korea Anti-tumor Drug Market Size and Forecast (2017-2028)

8.3.5 India Anti-tumor Drug Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Anti-tumor Drug Market Size and Forecast (2017-2028)

8.3.7 Australia Anti-tumor Drug Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Anti-tumor Drug Revenue by Type (2017-2028)

9.2 South America Anti-tumor Drug Revenue by Application (2017-2028)

9.3 South America Anti-tumor Drug Market Size by Country

9.3.1 South America Anti-tumor Drug Revenue by Country (2017-2028)

9.3.2 Brazil Anti-tumor Drug Market Size and Forecast (2017-2028)

9.3.3 Argentina Anti-tumor Drug Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Anti-tumor Drug Revenue by Type (2017-2028)

10.2 Middle East & Africa Anti-tumor Drug Revenue by Application (2017-2028)

10.3 Middle East & Africa Anti-tumor Drug Market Size by Country

10.3.1 Middle East & Africa Anti-tumor Drug Revenue by Country (2017-2028)

10.3.2 Turkey Anti-tumor Drug Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Anti-tumor Drug Market Size and Forecast (2017-2028)

10.3.4 UAE Anti-tumor Drug Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Anti-tumor Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Anti-tumor Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Anti-tumor Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Anti-tumor Drug Revenue (USD Million) by Region (2017-2022)

Table 5. Global Anti-tumor Drug Revenue Market Share by Region (2023-2028)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche Anti-tumor Drug Product and Solutions

Table 9. Roche Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Anti-tumor Drug Product and Solutions

Table 13. Novartis Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Celgene Corporate Information, Head Office, and Major Competitors

Table 15. Celgene Major Business

Table 16. Celgene Anti-tumor Drug Product and Solutions

Table 17. Celgene Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 19. Bristol-Myers Squibb Major Business

Table 20. Bristol-Myers Squibb Anti-tumor Drug Product and Solutions

Table 21. Bristol-Myers Squibb Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Amgen Corporate Information, Head Office, and Major Competitors

Table 23. Amgen Major Business

Table 24. Amgen Anti-tumor Drug Product and Solutions

Table 25. Amgen Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 27. Johnson & Johnson Major Business

Table 28. Johnson & Johnson Anti-tumor Drug Product and Solutions

Table 29. Johnson & Johnson Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Pfizer Corporate Information, Head Office, and Major Competitors

Table 31. Pfizer Major Business

Table 32. Pfizer Anti-tumor Drug Product and Solutions

Table 33. Pfizer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Takeda Corporate Information, Head Office, and Major Competitors

Table 35. Takeda Major Business

Table 36. Takeda Anti-tumor Drug Product and Solutions

Table 37. Takeda Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 39. Eli Lilly Major Business

Table 40. Eli Lilly Anti-tumor Drug Product and Solutions

Table 41. Eli Lilly Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 43. AstraZeneca Major Business

Table 44. AstraZeneca Anti-tumor Drug Product and Solutions

Table 45. AstraZeneca Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Astellas Corporate Information, Head Office, and Major Competitors

Table 47. Astellas Major Business

Table 48. Astellas Anti-tumor Drug Product and Solutions

Table 49. Astellas Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Merck & Co Corporate Information, Head Office, and Major Competitors

Table 51. Merck & Co Major Business

Table 52. Merck & Co Anti-tumor Drug Product and Solutions

Table 53. Merck & Co Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Sanofi Corporate Information, Head Office, and Major Competitors

Table 55. Sanofi Major Business

Table 56. Sanofi Anti-tumor Drug Product and Solutions

Table 57. Sanofi Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Bayer Corporate Information, Head Office, and Major Competitors

Table 59. Bayer Major Business

Table 60. Bayer Anti-tumor Drug Product and Solutions

Table 61. Bayer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Biogen Idec Corporate Information, Head Office, and Major Competitors

Table 63. Biogen Idec Major Business

Table 64. Biogen Idec Anti-tumor Drug Product and Solutions

Table 65. Biogen Idec Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Eisai Corporate Information, Head Office, and Major Competitors

Table 67. Eisai Major Business

Table 68. Eisai Anti-tumor Drug Product and Solutions

Table 69. Eisai Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Teva Corporate Information, Head Office, and Major Competitors

Table 71. Teva Major Business

Table 72. Teva Anti-tumor Drug Product and Solutions

Table 73. Teva Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Otsuka Corporate Information, Head Office, and Major Competitors

Table 75. Otsuka Major Business

Table 76. Otsuka Anti-tumor Drug Product and Solutions

Table 77. Otsuka Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Global Anti-tumor Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 79. Global Anti-tumor Drug Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 80. Breakdown of Anti-tumor Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. Anti-tumor Drug Players Head Office, Products and Services Provided

Table 82. Anti-tumor Drug Mergers & Acquisitions in the Past Five Years

Table 83. Anti-tumor Drug New Entrants and Expansion Plans

Table 84. Global Anti-tumor Drug Revenue (USD Million) by Type (2017-2022)

Table 85. Global Anti-tumor Drug Revenue Share by Type (2017-2022)

Table 86. Global Anti-tumor Drug Revenue Forecast by Type (2023-2028)

Table 87. Global Anti-tumor Drug Revenue by Application (2017-2022)

Table 88. Global Anti-tumor Drug Revenue Forecast by Application (2023-2028)

Table 89. North America Anti-tumor Drug Revenue by Type (2017-2022) & (USD Million)

Table 90. North America Anti-tumor Drug Revenue by Type (2023-2028) & (USD Million)

Table 91. North America Anti-tumor Drug Revenue by Application (2017-2022) & (USD Million)

Table 92. North America Anti-tumor Drug Revenue by Application (2023-2028) & (USD Million)

Table 93. North America Anti-tumor Drug Revenue by Country (2017-2022) & (USD Million)

Table 94. North America Anti-tumor Drug Revenue by Country (2023-2028) & (USD Million)

Table 95. Europe Anti-tumor Drug Revenue by Type (2017-2022) & (USD Million)

Table 96. Europe Anti-tumor Drug Revenue by Type (2023-2028) & (USD Million)

Table 97. Europe Anti-tumor Drug Revenue by Application (2017-2022) & (USD Million)

Table 98. Europe Anti-tumor Drug Revenue by Application (2023-2028) & (USD Million)

Table 99. Europe Anti-tumor Drug Revenue by Country (2017-2022) & (USD Million)

Table 100. Europe Anti-tumor Drug Revenue by Country (2023-2028) & (USD Million)

Table 101. Asia-Pacific Anti-tumor Drug Revenue by Type (2017-2022) & (USD Million)

Table 102. Asia-Pacific Anti-tumor Drug Revenue by Type (2023-2028) & (USD Million)

Table 103. Asia-Pacific Anti-tumor Drug Revenue by Application (2017-2022) & (USD Million)

Table 104. Asia-Pacific Anti-tumor Drug Revenue by Application (2023-2028) & (USD Million)

Table 105. Asia-Pacific Anti-tumor Drug Revenue by Region (2017-2022) & (USD Million)

Table 106. Asia-Pacific Anti-tumor Drug Revenue by Region (2023-2028) & (USD Million)

Table 107. South America Anti-tumor Drug Revenue by Type (2017-2022) & (USD Million)

Table 108. South America Anti-tumor Drug Revenue by Type (2023-2028) & (USD Million)

Table 109. South America Anti-tumor Drug Revenue by Application (2017-2022) & (USD Million)

Table 110. South America Anti-tumor Drug Revenue by Application (2023-2028) & (USD Million)

Table 111. South America Anti-tumor Drug Revenue by Country (2017-2022) & (USD Million)

Table 112. South America Anti-tumor Drug Revenue by Country (2023-2028) & (USD Million)

Table 113. Middle East & Africa Anti-tumor Drug Revenue by Type (2017-2022) & (USD Million)

Table 114. Middle East & Africa Anti-tumor Drug Revenue by Type (2023-2028) & (USD Million)

Table 115. Middle East & Africa Anti-tumor Drug Revenue by Application (2017-2022) & (USD Million)

Table 116. Middle East & Africa Anti-tumor Drug Revenue by Application (2023-2028) & (USD Million)

Table 117. Middle East & Africa Anti-tumor Drug Revenue by Country (2017-2022) & (USD Million)

Table 118. Middle East & Africa Anti-tumor Drug Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Anti-tumor Drug Picture

Figure 2. Global Anti-tumor Drug Revenue Market Share by Type in 2021

Figure 3. Cytotoxic Drugs

Figure 4. Non-cytotoxic Drugs

Figure 5. Anti-tumor Drug Revenue Market Share by Application in 2021

Figure 6. Alkylating Agents Picture

Figure 7. Anti-Metabolism Drugs Picture

Figure 8. Platinum Antineoplastic Agents Picture

Figure 9. Anthracycline Antitumor Drugs Picture

Figure 10. Microtubule Stabilizer Picture

Figure 11. Endocrine Therapy Drugs Picture

Figure 12. Immunotherapy Drugs Picture

Figure 13. Gene Therapy Drugs Picture

Figure 14. Targeted Antineoplastic Drugs Picture

Figure 15. Global Anti-tumor Drug Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Anti-tumor Drug Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Anti-tumor Drug Revenue Market Share by Region (2017-2028)

Figure 18. Global Anti-tumor Drug Revenue Market Share by Region in 2021

Figure 19. North America Anti-tumor Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Anti-tumor Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Anti-tumor Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Anti-tumor Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Anti-tumor Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Anti-tumor Drug Market Drivers

Figure 25. Anti-tumor Drug Market Restraints

Figure 26. Anti-tumor Drug Market Trends

Figure 27. Roche Recent Developments and Future Plans

Figure 28. Novartis Recent Developments and Future Plans

Figure 29. Celgene Recent Developments and Future Plans

Figure 30. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 31. Amgen Recent Developments and Future Plans

Figure 32. Johnson & Johnson Recent Developments and Future Plans

Figure 33. Pfizer Recent Developments and Future Plans

Figure 34. Takeda Recent Developments and Future Plans

Figure 35. Eli Lilly Recent Developments and Future Plans

Figure 36. AstraZeneca Recent Developments and Future Plans

Figure 37. Astellas Recent Developments and Future Plans

Figure 38. Merck & Co Recent Developments and Future Plans

Figure 39. Sanofi Recent Developments and Future Plans

Figure 40. Bayer Recent Developments and Future Plans

Figure 41. Biogen Idec Recent Developments and Future Plans

Figure 42. Eisai Recent Developments and Future Plans

Figure 43. Teva Recent Developments and Future Plans

Figure 44. Otsuka Recent Developments and Future Plans

Figure 45. Global Anti-tumor Drug Revenue Share by Players in 2021

Figure 46. Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 47. Global Top 3 Players Anti-tumor Drug Revenue Market Share in 2021

Figure 48. Global Top 10 Players Anti-tumor Drug Revenue Market Share in 2021

Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 50. Global Anti-tumor Drug Revenue Share by Type in 2021

Figure 51. Global Anti-tumor Drug Market Share Forecast by Type (2023-2028)

Figure 52. Global Anti-tumor Drug Revenue Share by Application in 2021

Figure 53. Global Anti-tumor Drug Market Share Forecast by Application (2023-2028)

Figure 54. North America Anti-tumor Drug Sales Market Share by Type (2017-2028)

Figure 55. North America Anti-tumor Drug Sales Market Share by Application (2017-2028)

Figure 56. North America Anti-tumor Drug Revenue Market Share by Country (2017-2028)

Figure 57. United States Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Canada Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Mexico Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Europe Anti-tumor Drug Sales Market Share by Type (2017-2028)

Figure 61. Europe Anti-tumor Drug Sales Market Share by Application (2017-2028)

Figure 62. Europe Anti-tumor Drug Revenue Market Share by Country (2017-2028)

Figure 63. Germany Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. France Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. United Kingdom Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Russia Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Italy Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Asia-Pacific Anti-tumor Drug Sales Market Share by Type (2017-2028)

Figure 69. Asia-Pacific Anti-tumor Drug Sales Market Share by Application (2017-2028)

Figure 70. Asia-Pacific Anti-tumor Drug Revenue Market Share by Region (2017-2028)

Figure 71. China Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Japan Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South Korea Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. India Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Australia Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. South America Anti-tumor Drug Sales Market Share by Type (2017-2028)

Figure 78. South America Anti-tumor Drug Sales Market Share by Application (2017-2028)

Figure 79. South America Anti-tumor Drug Revenue Market Share by Country (2017-2028)

Figure 80. Brazil Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Argentina Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Middle East and Africa Anti-tumor Drug Sales Market Share by Type (2017-2028)

Figure 83. Middle East and Africa Anti-tumor Drug Sales Market Share by Application (2017-2028)

Figure 84. Middle East and Africa Anti-tumor Drug Revenue Market Share by Country (2017-2028)

Figure 85. Turkey Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. UAE Anti-tumor Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. Methodology

Figure 89. Research Process and Data Source